Skip to main content Accessibility help
×
Home

Gut Hormones in Glucose Homeostasis

  • V Marks (a1), Linda Morgan (a1), J Oben (a1) and R Elliott (a1)
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Gut Hormones in Glucose Homeostasis
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Gut Hormones in Glucose Homeostasis
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Gut Hormones in Glucose Homeostasis
      Available formats
      ×

Abstract

  • An abstract is not available for this content so a preview has been provided below. To view the full text please use the links above to select your preferred format.

Copyright

References

Hide All
Andersen, D. K., Elahi, D., Brown, J. C., Tobin, J. D. & Andres, R. (1978). Oral glucose augmentation of insulin secretion. Journal of Clinical Investigation 62, 152161.
Arendt, J., Hampton, S., English, J., Kwasowski, P. & Marks, V. (1982). 24-hour profiles of melatonin, cortisol, insulin. C-peptide and GIP following a meal and subsequent fasting. Clinical Endocrinology 16, 8995.
Bailey, C. J. & Flatt, P. R. (1988). Thc enteroinsular axis in animals with hyperinsulinaemic and hypoinsulinaemic diabetes. Frontiers in Diabetes Research II . pp. 217224 [Shafrir, E. and Renold, A. E., editors]. London: John Libbey and Co.
Block, M. B., Hofeldt, F. D., Lufkin, E. G., Haglar, L. & Herman, R. H. (1977). The response of glucagon-like immunoreactivity to reactive hypoglycemia. Military Medicine 142, 3237.
Bloom, S. R., Royston, C. M. S. & Thomson, J. P. S. (1972). Enteroglucagon release in the dumping syndrome. Lancet ii, 789793.
Brown, J. C. (1982). Gastric Inhibitory Polypeptide. Heidelberg & New York: Springer-Verlag.
Brown, J. C. & Dryburgh, J. R. (1971). A gastric inhibitory polypeptide II: the complete amino acid sequence. Canadian Journal of Biochemistry 49, 867872.
Brown, J. C., Mutt, V. & Pederson, R. A. (1970). Further purification of a polypeptide demonstrating enterogastrone activity. Journal of Physiology 209, 5764.
Charles, M. A. & Waldeck, N. (1981). Excessive circulating large molecular weight immunoreactive glucagon components in subjects with the idiopathic postprandial syndrome. Journal of Clinicul Endocrinology and Metabolism 53, 366371.
Creutzfeldt, W. (1979). The incretin concept today. Diabetologia 16, 7585.
Creutzfeldt, W. & Ebert, R. (1985). New developments in the incretin concept. Diabetologia 28, 565573.
Dupré, J., Ross, S. A., Watson, D. & Brown, J. C. (1973). Stimulation of insulin secretion by gastric inhibitory polypeptide in man. Journal of Clinical Endocrinology and Metabolism 37, 826828.
Ebert, R. & Creutzfeldt, W. (1982). Influence of gastric inhibitory polypeptide antiserum on glucose-stimulated insulin secretion in rats. Endocrinology 111, 16011606.
Elahi, D., Andersen, D. K., Muller, D. C., Tobin, J. D., Brown, J. C. & Andres, R. (1984). The enteric enhancement of glucose-stimulated insulin release: the role of GIP in aging, obesity and non-insulin dependent diabetes mellitus. Diabetes 33, 950957.
Foster, G. L. (1923). Studies on carbohydrate metabolism: I. Some comparisons of blood sugar concentration in venous blood and finger prick blood. Journal of Biological Chemistry 55, 291302.
ke, R., Fehmann, H.-C. & Göke, B. (1991). Glucagon-like peptide-1 (7-36) amide is a new incretin/enterogastrone candidate. European Journal of Clinical Investigation 21, 135144.
Hampton, S. M., Morgan, L. M., Tredger, J. A., Cramb, R. & Marks, V. (1986). Insulin and C-peptide levels after oral and intravenous glucose: contribution of enteroinsular axis to insulin secretion. Diabetes 35, 612616.
Holst, J. J., Ørskov, C. & Bersani, M. (1991). Heterogeneity of islet hormones. In The Endocrine Pancreas, pp. 125149 [Samols, E., editor]. New York: Raven Press.
Jones, I. R., Owens, D. K., Luzio, S. D. & Hayes, T. M. (1989 a). Obesity is associated with increased post-prandial GIP levels which are not reduced by dietary restriction and weight loss. Diabète & Métabolisme Paris 15, 1122.
Jones, I. R., Owens, D. R., Luzio, S. & Hayes, T. M. (1989 b). Glucose dependent insulinotropic polypeptide (GIP) infused intravenously is insulinotropic in the fasting state in Type 2 (non-insulin-dependent) diabetes mellitus. Hormone Metabolism Researc 21, 2326.
Komatsu, R., Matsuyama, T., Namba, M., Wanatabe, N., Itoh, H., Kono, N. & Tarui, S. (1989). Glucagonostatic acid insulinotropic action of glucagon-like peptide 1 (7-36) amide. Diabetes 38, 902905.
Kreymann, B., Ghatei, M. A., Williams, G. & Bloom, S. R. (1987). Glucagon-like peptide- 1 (7-36): a physiological incretin in man. Lancet ii, 13001304.
McIntyre, N., Holdsworth, C. D. & Turner, D. S. (1964). New interpretation of oral glucose tolerance. Lancet ii, 2021.
Makman, M. H. & Sutherland, E. W. (1964). Use of liver adenyl cyclase for assay of glucagon in human gastrointestinal tract and panereas. Endocrinology 75, 127134.
Marks, V. (1970). The effect of fructose and galactose on insulin secretion in man. Proceedings of an International Symposium on the Clinical and Metabolic Aspects of Laevulose, pp. 3741. Crewe: Calmic Ltd.
Marks, V. (1987). Glycaemic stability in healthy subjects: fluctuations in blood glucose concentration during the day. In Hypoglycemia: Serono Symposia Publications no. 38. pp. 1924 [Andreani, D., Marks, V. and Lefebvre, P. J., editors]. New York: Raven Press.
Marks, V. (1988). GIP–the obesity hormone. In Current Approaches: Obesity [James, W. P. T. and Parker, S. W., editors]. London: Duphar Laboratories.
Marks, V. & Morgan, L. (1984). The entero-insular axis. In Recent Advances in Diabetes. pp. 5571. [Nattrass, M. and Santiago, J. V., editors]. Edinburgh: Churchill Livingstone.
Marks, V. & Samols, E. (1970). Intestinal factors in the regulation of insulin secretion. Advances in Metabolic Disorders 4, 138.
Marks, V. & Turner, D. S. (1977). The gastrointestinal hormones with particular reference to their role in the regulation of insulin secretion. Essays in Medical Biochemistry 3, 109152.
Morgan, L. M., Morris, B. A. & Marks, V. (1978). Radioimmunoassay of gastric inhibitory polypeptide. Annals of Clinical Biochemistry 15, 172177.
Morgan, L. M., Oben, J., Fletcher, J. & Marks, V. (1991). Metabolic effects of gut peptides. In Control of Lean and Fat Deposition - 51st Easter School in Agricultural Science, Nottingham University (In the Press).
Morgan, L. M., Tredger, J. A. T., Hampton, S. M., French, A. P., Peake, J. C. F. & Marks, V. (1988). The effect of dietary modification and hyperglycaemia in gastric emptying and gastric inhibitory polypeptide (GIP) secretion. British Journal of Nutrition 60, 2937.
Morgan, L. M., Wright, J. W. & Marks, V. (1979). The effect of oral galactose on GIP and insulin secretion in man. Diabetologia 16, 235239.
Peters, J. P. & van Slyke, D. D. (1946). Quantitative Clinical Chemistry Interpretations. vol. 1. London: Bailliere, Tindall & Cox.
Samols, E., Tyler, J., Marri, G. & Marks, V. (1965). Stimulation of glucagon secretion by oral glucose. Lancet ii, 12571259.
Samols, E. & Marks, V. (1967). Nouvelles conceptions sur la signification fonctionnelle du glucagon (pancréatique et extrapancréatique). Journees annuelles de Diabétologie de l'Hotel-Dieu, pp. 4346. Paris: Editions Médicales Flammarion.
Samols, E. & Stagner, J. I. (1991). Intraislet and islet-acinar portal systems and their significance. In The Endocrine Pancreas, pp. 93124 [Samols, E., editor]. New York: Raven Press.
Samols, E., Tyler, J., Megyesi, C. & Marks, V. (1966). Immunochemical glucagon in human pancreas, gut and plasma. Lancet ii, 727729.
Sarson, D. L., Wood, S. M., Holder, D. & Bloom, S. R. (1982). The effect of glucose-dependent insulinotropic polypeptide infused at physiological concentrations on the release of insulin in man. Diabetologia 22, 3336.
Service, F. J. & Nelson, R. L. (1980) Characteristics of glycemic stability. Diabetes Care 3, 5862.
Shuster, L. T., Go, V. L. W., Rizza, R. A., O'Brien, P. C. & Service, F. J. (1988). Potential incretins. Mayo Clinic Proceedings 63, 794800.
Sykes, S., Morgan, L. M., English, J. & Marks, V. (1980). Evidence for the preferential stimulation of gastric inhibitory polypeptide secretion in the rat by actively transported carbohydrates and their analogues. Journal of Endocrinology 85, 201207.
Takemura, J., Seino, Y., Yamamura, T., Tsuda, K., Seino, S., Itoh, N. & Imura, H. (1982). The role of endogenous gastric inhibitory polypeptide in the enteroinsular axis. Journal of Clinical Endocrinology and Metabolism 54, 909913.
Taminato, T., Seino, Y., Goto, Y., Inoue, Y., Kadowaki, S., Mori, K., Nozawa, M., Yajima, H. & Imura, H. (1977). Synthetic gastric inhibitory polypeptide: stimulatory effect on insulin and glucagon secretion in the rat. Diabetes 26, 480484.
Turner, D. S., Etheridge, L., Marks, V., Brown, J. C. & Mutt, V. (1974). Effectiveness of the intestinal polypeptides. IRP. GIP. VIP and Motilin on insulin release in the rat. Diabetologia 10, 459463.
Turner, D. S., Shabaan, A., Etheridge, L. & Marks, V. (1973). The effect of an intestinal polypeptide fraction on insulin release in the rat in vitro and in vivo. Endocrinology 93, 13231328.

Gut Hormones in Glucose Homeostasis

  • V Marks (a1), Linda Morgan (a1), J Oben (a1) and R Elliott (a1)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed